Michael Cloonan

Sage Therapeutics

Chief Business Officer

Overview

Annual data

2017

In 2017, Michael Cloonan earned a total compensation of $10,043,744 as Chief Business Officer at Sage Therapeutics.

Ranking586 out of 13,165
Percentile95.5%

Michael Cloonan's 2017 compensation ranked 586th out of 13,165 executive pay records tracked by us this year.

Michael Cloonan earned more than 95.5% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking27 out of 1,094
Percentile97.5%

In the industry of pharmaceutical preparations, Michael Cloonan's 2017 pay ranked 27th, among 1,094 executive pay records.

Michael Cloonan earned more than 97.5% of executives in this industry.

Bonus$125,000
Non-Equity Incentive Plan$170,016
Option Awards$9,439,278
Salary$301,795
Other$7,655
Total$10,043,744

Cloonan received $9,439,278 in option awards, which accounts for 93.98% of total compensation.

Cloonan also received $125,000 in bonus, $170,016 in non-equity incentive plan, $301,795 in salary and $7,655 in other compensation.